Elevidys (delandistrogene moxeparvovec-rokl) NDC 60923-552

Product information

Brand name (proprietary)

Elevidys

Generic name (nonproprietary)

delandistrogene moxeparvovec-rokl

Dosage form

Kit

Route

Intravenous

Labeler

Sarepta Therapeutics, Inc.

Product type

Prescription drug

Marketing category

BLA — Biologics License ApplicationApplication BLA 125781

Marketing start

Jun 22, 2023

Listing expires

Dec 31, 2027

Identifiers

Product ID 60923-552_a96a4f2b-47a9-4175-b3c4-78a0c9350a09SPL ID a96a4f2b-47a9-4175-b3c4-78a0c9350a09SPL set ID 3525abcd-fbd2-46c5-9706-cffdf2e8a361RxCUI 797544, 2641679, 2641685, 2641687, 2641688, 2641689, 2641690, 2641691, 2641692, 2641693, 2641694, 2641695, 2641696, 2641697, 2641698, 2641699, 2641700, 2641701, 2641702, 2641703, 2641704, 2641705, 2641706, 2641707, 2641708, 2641709, 2641710, 2641711, 2641712, 2641713, 2641714, 2641715, 2641716, 2641717, 2641718, 2641719, 2641720, 2641721, 2641722, 2641723, 2641724, 2641725, 2641726, 2641727, 2641728, 2641729, 2641730, 2641731, 2641732, 2641733, 2641734, 2641735, 2641736, 2641737, 2641738, 2641739, 2641740, 2641741, 2641742, 2641743, 2641744, 2641745, 2641746, 2641747, 2641748, 2641750, 2641751, 2641752, 2641753, 2641754, 2641755, 2641756, 2641757, 2641758, 2641759, 2641760, 2641761, 2641762, 2641763, 2641764, 2641765, 2641766, 2641767, 2641768, 2641769, 2641770, 2641771, 2641772, 2641773, 2641774, 2641775, 2641776, 2641777, 2641778, 2641779, 2641780, 2641781, 2641782, 2641783, 2641784, 2641785, 2641786, 2641787, 2641788, 2641789, 2641830, 2641831, 2641832, 2641833, 2641834, 2641835, 2641836, 2641837, 2641838, 2641839, 2641840, 2641841, 2641842, 2641843, 2641844, 2641845, 2641846, 2641847, 2641848, 2641849UPC 0360923501108, 0360923528372, 0360923540497, 0360923521304, 0360923509180, 0360923542514, 0360923541500, 0360923526354, 0360923559680, 0360923544532, 0360923536452, 0360923525340, 0360923547564, 0360923537466, 0360923503126, 0360923502112, 0360923533420, 0360923505144, 0360923514238, 0360923519288, 0360923529386, 0360923550595, 0360923518274, 0360923517260, 0360923527368, 0360923522318, 0360923515242, 0360923553626, 0360923520291, 0360923512210, 0360923555644, 0360923546550, 0360923551608, 0360923524336, 0360923561706, 0360923552612, 0360923513224, 0360923530399, 0360923554630, 0360923543528, 0360923534434, 0360923504130, 0360923548578, 0360923511206, 0360923510193, 0360923507162, 0360923532416, 0360923557662, 0360923535448, 0360923539484, 0360923538470, 0360923549582, 0360923506158, 0360923556658, 0360923545546, 0360923516256, 0360923560693, 0360923558676, 0360923508176, 0360923531402, 0360923523322

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N460923055261 followed by a unit qualifier and the quantity Copy

Package 60923-0552-61. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under BLA 125781

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 40.